Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid Drug Desensitization With Rituximab in 24 Cases: A Single-Center Experience.
Görgülü B, Seval GC, Kendirlinan R, Toprak SK, Özcan M, Bavbek S. Görgülü B, et al. Among authors: kendirlinan r. J Investig Allergol Clin Immunol. 2019;29(6):468-470. doi: 10.18176/jiaci.0445. Epub 2019 Sep 18. J Investig Allergol Clin Immunol. 2019. PMID: 31530515 Free article. No abstract available.
Does the medical diagnosis of occupational asthma coincide with the legal diagnosis?
Çelebi Sözener Z, Aydın Ö, Demirel YS, Soyyiğit Ş, Çerçi P, Kendirlinan R, Bavbek S, Çelik GE, Misirligil Z, Sin BA, Keleşoğlu A, Mungan D. Çelebi Sözener Z, et al. Among authors: kendirlinan r. J Asthma. 2017 Nov;54(9):930-937. doi: 10.1080/02770903.2016.1277541. Epub 2017 Jan 5. J Asthma. 2017. PMID: 28055274
Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in adults: Beyond current classification.
Çerçi P, Kendirlinan R, Büyüköztürk S, Gelincik A, Ünal D, Demir S, Erkekol FÖ, Karakaya G, Dursun AB, Çelikel S, Ediger D, Abadoglu O, Bavbek S. Çerçi P, et al. Among authors: kendirlinan r. Allergol Immunopathol (Madr). 2023 Sep 1;51(5):84-92. doi: 10.15586/aei.v51i5.946. eCollection 2023. Allergol Immunopathol (Madr). 2023. PMID: 37695234
Influencing factors on the safety and effectiveness of venom immunotherapy.
Arzt-Gradwohl L, Annik Herzog S, Aberer W, Alfaya Arias T, Antolín-Amérigo D, Bonadonna P, Boni E, Bożek A, Chełmińska M, Ernst B, Frelih N, Gawlik R, Gelincik A, Hawranek T, Hoetzenecker W, Jiménez Blanco A, Kita K, Kendirlinan R, Košnik M, Laipold K, Lang R, Marchi F, Mauro M, Nittner-Marszalska M, Poziomkowska-Gęsicka I, Pravettoni V, Preziosi D, Quercia O, Reider N, Rosiek-Biegus M, Ruiz-Leon B, Schrautzer C, Serrano P, Sin A, Ayşe Sin B, Stoevesandt J, Trautmann A, Vachová M, Johannes Sturm G. Arzt-Gradwohl L, et al. Among authors: kendirlinan r. J Investig Allergol Clin Immunol. 2023 Nov 8:0. doi: 10.18176/jiaci.0967. Online ahead of print. J Investig Allergol Clin Immunol. 2023. PMID: 37937715 Free article.
20 results